Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Sell
5,152
-378
-7% -$20.5K 0.01% 532
2025
Q4
$271K Buy
5,530
+1,396
+34% +$65.1K 0.01% 534
2025
Q3
$178K Buy
4,134
+3,383
+450% +$132K ﹤0.01% 619
2025
Q2
$28.8K Buy
+751
New +$28.7K ﹤0.01% 758
2022
Q3
Sell
-4,724
Closed -$257K 254
2022
Q2
$257K Hold
4,724
0.03% 228
2022
Q1
$257K Buy
+4,724
New +$257K 0.02% 239
2021
Q4
Sell
-4,724
Closed -$226K 267
2021
Q3
$226K Sell
4,724
-293
-6% -$14.7K 0.02% 247
2021
Q2
$250K Buy
+5,017
New +$241K 0.02% 248
2016
Q4
Sell
-3,826
Closed -$207K 135
2016
Q3
$207K Hold
3,826
0.08% 131
2016
Q2
$208K Buy
+3,826
New +$202K 0.08% 136
2016
Q1
Sell
-4,038
Closed -$203K 134
2015
Q4
$203K Buy
+4,038
New +$206K 0.09% 132
2014
Q2
Sell
-562
Closed -$35K 164
2014
Q1
$35K Buy
+562
New +$38K 0.02% 145

Other funds holding GSK

Atlantic Union Bankshares's GSK Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its GSK (GSK) stake by 6.8% in Q1 2026, selling an estimated $20.5K and leaving 5,152 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #532.

Atlantic Union Bankshares first reported a position in GSK in Q1 2014 and has held it in 12 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Atlantic Union Bankshares held 5,152 shares of GSK worth $284K as of Q1 2026.
  • Atlantic Union Bankshares sold 378 GSK shares in Q1 2026, an estimated $20.5K.
  • GSK made up 0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #532 holding.
  • Atlantic Union Bankshares first reported a position in GSK in Q1 2014 and has held it in 12 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.